Development of a Recombinant Vaccine Against Japanese Encephalitis

References

• Ashok MS, Rangarajan PN (1999). Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese encephalitis virus confers significant protec-tion against intracerebral viral challenge without induc-ing detectable antiviral antibodies. Vaccine 18: 68–75.
   PubMed Web of Science ®Google Scholar
• Ashok MS, Rangarajan PN (2000). Evaluation of the potency of BIKEN inactivated Japanese Encephali-tis vaccine and DNA vaccines in an intracerebral Japanese Encephalitis virus challenge. Vaccine 19: 155–157.
   PubMed Web of Science ®Google Scholar
• Bartelma G, Padmanabhan R (2002). Expression, purifica-tion, and characterization of the RNA 5'-triphosphatase activity of dengue virus type 2 nonstructural protein 3. Virology 299: 122–132.
   PubMed Web of Science ®Google Scholar
• Bhatt TR, Crabtree MB, Guirakhoo F, Monath TP, Miller BR (2000). Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14-14-2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am J Trop Med Hyg 62: 480–484.
   PubMed Web of Science ®Google Scholar
• Bista MB, Banerjee MK, Shin SH, Tandan JB, Kim MH, Sohn YM, Ohrr HC, Tang JL, Halstead SB (2001). Effi-cacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358: 791–795.
   PubMed Web of Science ®Google Scholar
• Bray M, Lai CJ (1991). Dengue virus premembrane and membrane proteins elicit a protective immune response. Virology 185: 505–508.
   PubMed Web of Science ®Google Scholar
• Cardiff RD, Lund JK (1975). Distribution of dengue 2 anti-gens by electron immunocytochemistry. Infect Immun 13: 1699–1709.
   Google Scholar
• Chambers TJ, Hahn CS, Galler R, Rice CM (1990). Flavivirus genome organization, expression and replication. Annu Rev Microbic)] 44: 649–688.
   PubMed Web of Science ®Google Scholar
• Chambers TJ, Nestorowicz A, Mason PW, Rice CM (1999). Yellow Fever/Japanese encephalitis chimeric viruses: construction and biological properties. I Virol 73: 3095–3101.
   PubMed Web of Science ®Google Scholar
• Chang G-JJ, Hunt AR, Davis B (2000). A single intramuscu-lar injection of recombinant plasmid DNA induces pro-tective immunity and prevents Japanese encephalitis in mice. J Virol 74: 4244–4252.
   PubMed Web of Science ®Google Scholar
• Chen H-W, Pan C-H, Liau M-Y, Jou R, Tsa C-J, Wu H-J, Lin Y-L, Tao M-H (1999). Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73: 10137–10145.
   PubMed Web of Science ®Google Scholar
• Davis BS, Chang GJ, Cropp B, Roehrig JT, Martin DA, Mitchell CJ, Bowen R, Bunning ML (2001). West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 75: 4040–4047.
   Google Scholar
• Gould EA, Buckley A, Barrette ADT, Cammack N (1986). Neutralizing (54 K) and non-neutralizing (54 K and 58 K) monoclonal antibodies against the structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol 67: 591–596.
   Google Scholar
• Guirakhoo F, Bolin RA, Roehrig JT (1992). The Murray Valley encephalitis virus prM protein confers acid re-sistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virol-ogy 191: 921–931.
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrette ADT, Monath TP (1999). Immunogenecity, genetic stability, and protective efficacy of a recombi-nant chimaeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese necephalitis. Virology 257: 363–372.
   PubMed Web of Science ®Google Scholar
• Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, Pyke AT, Johansen CA, Mackenzie JS (1999). Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 170: 533–536.
   Google Scholar
• Hanna JN, Ritchie SA, Phillips DA, Shield J, Bailey MC, Mackenzie JS, Poidinger M, McCall BJ, Mills PJ (1996). An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 165: 256–260.
   Google Scholar
• Hawkes RA, Roehrig JT, Hunt AR, Moore GA (1988). Anti-genic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol 69: 1105–1109.
   PubMed Web of Science ®Google Scholar
• Igarashi A, Tanaka M, Morita K, Takasu T, Ahmed A, Ahmed A, Akram DS, Waqar MA (1994). Detection of west Nile and Japanese encephalitis viral genome se-quences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbic)] Immunol 38: 827–830.
   PubMed Web of Science ®Google Scholar
• Jan L-R, Yang C-S, Henchal LS, Sumiyoshi H, Summers PL, Dubois DR, Lai C-J (1993). Increased immunogenecity and protective efficacy in outbred and inbred mice by strategic carboxyl terminal truncation of Japanese en-cephalitis virus envelope glycoprotein. Am J Trop Med Hyg 48: 412–423.
   PubMed Web of Science ®Google Scholar
• Kanesa-Thasan N, Smucny JJ, Hoke CHJ, Marks DH, Konishi E, Kurane I, Tang DB, Mason PW, Shope RE (2001). Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus-poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine 19: 483–491.
   Google Scholar
• Kaur R, Sachdeva G, Vrati S (2002). Plasmid DNA immu-nization against Japanese encephalitis virus: immuno-genicity of membrane-anchored and secretory envelope protein. J Infect Dis 185: 1–12.
   PubMed Web of Science ®Google Scholar
• Kimura-Kiroda J, Yasui K (1988). Protection of mice against Japanese encephalitis virus by passive administration of monoclonal antibodies. J Immunol 141: 3606–3610.
   PubMed Web of Science ®Google Scholar
• Kolaskar AS, Kulkarni-Kale U (1999). Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese en-cephalitis virus. Virology 261: 31–42.
   Web of Science ®Google Scholar
• Konishi E, Fujii A, Mason PW (2001). Generation and char-acterization of a mammalian cell line continously ex-pressing Japanese encephalitis virus subviral particles. J Virol 75: 2204–2212.
   PubMed Web of Science ®Google Scholar
• Konishi E, Kurane I, Mason PW, Shope RE, Ennis FA (1997). Poxvirus based Japanese encephalitis vaccine candi-dates induce JE virus specific CD8+ cytotoxic T lym-phocytes in mice. Virology 227: 353–360.
   PubMedGoogle Scholar
• Konishi E, Mason PW (1993). Proper maturation of the Japanese encephalitis virus envelope glycoprotein re-quires cosynthesis with the premembrane protein. J Virol 67: 1672–1675.
   PubMed Web of Science ®Google Scholar
• Konishi E, Pincus S, Beneditto ALF, Robert ES, Paoletti E, Mason PW (1991). Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology 185: 401–410.
   PubMed Web of Science ®Google Scholar
• Konishi E, Pincus S, Paoletti E, Laegreid WW, Shope RE, Mason PW (1992). A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of japanese encephalitis virus prevents JEV viremia in swine. Virology 190: 454–458.
   PubMed Web of Science ®Google Scholar
• Konishi E, Pincus S, Paoletti E, Shope RE, Mason PW (1994). Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combina-tion with purified subunit immunogens. Vaccine 12: 633–638.
   PubMed Web of Science ®Google Scholar
• Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Mason PW (1998). Induction of protective immunity against Japanese encephaltis in mice by immunization with a plasmid encoding Japanese encephalitis virus premem-brane and envelope genes. I Virol 72: 4925-4930.
   Google Scholar
• Konishi E, Yamaoka M, Kurane I, Mason PW (2000). Japanese encephalitis DNA vaccine candidates express-ing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Virology 268: 49–55.
   PubMed Web of Science ®Google Scholar
• Ku CC, King CC, Lin CY, Hsu HC, Chen LY, Yueh YY, Chang GJ (1994). Homologus and heterologus neutralization antibody responses after immunization with Japanese encephalitis vaccine amongst Taiwan children. I Med Virol 44: 122–131.
   PubMed Web of Science ®Google Scholar
• Lanar DE, Tine JA, Detaisne C, Seguin MC, Cox WI, Winslow JP, Ware LA, Kauffman EB, Gordon D, Ballou WR (1996). Attenuated vaccinia virus-circumsporozite protein recombinants confer protection against rodent malaria. Infect Immun 64: 1666–1671.
   Google Scholar
• Lee JM, Crooks AJ, Stephenson JR (1989). The synthesis and maturation of a non-structural extracellular antigen froom tick-borne encephalitis virus and its relationship to the intracellular NS1 protein. I Gen Virol 70: 335–343.
   PubMed Web of Science ®Google Scholar
• Lin Y-L, Chen L-K, Liao C-L, Yeh C-T, Ma S-H, Chen J-L, Huang Y-L, Chen S-S, Chiang H-Y (1998). DNA immu-nization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. I Virol 72: 191–200.
   PubMed Web of Science ®Google Scholar
• Liu ZL, Hennessy S, Strom BL, Tsai TF, Wan CM, Tang SC, Xiang CF, Bilker WB, Pan XP, Yao YJ, Xu ZW, Halstead SB (1997). Short-term safety of live attenuated Japanese encephalitis vaccine (5A14-14-2): results of a random-ized trial with 26,239 subjects. I Infect Dis 176: 1366–1369.
   PubMed Web of Science ®Google Scholar
• Lorenz IC, Allison SL, Heinz FX, Helenius A (2002). Fold-ing and dimerization of tick-borne encephalitis virus en-velope proteins prM and E in the endoplasmic reticu-lum. I Virol 76: 5480–5491.
   PubMed Web of Science ®Google Scholar
• Luckow VA, Summers MD (1988). Trends in the develope-ment of baculovirus expression vectors. Bio/Technology 6: 47.
   Web of Science ®Google Scholar
• Mackenzie JS, Johansen CA, Ritchie SA, van den Hurk AF, Hall RA (2002). Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephali-tis virus in Australasia. Curr Top Microbiol Immunol 267: 49–73.
   PubMed Web of Science ®Google Scholar
• Mandle CW, Heinz FX, Stockl E, Kunz C (1989). Genome sequence of tick-borne encephalitis virus (western sub-type) and comparative analysis of non-structural pro-teins with other flaviviruses. Virology 173: 291–301.
   Google Scholar
• Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, Burke DS, Fournier MJ, Mason TL (1989). Molecular charaterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. I Gen Virol 70: 2037–2049.
   Google Scholar
• Matsuura Y, Miyamoto M, Sato T, Morita C, Yasui K (1989). Characterization of Japanese encephalitis virus enve-lope protein expressed by recombinant baculovirus. Virology 173: 674–682.
   PubMed Web of Science ®Google Scholar
• McCown JM, Cochran M, Putnak R, Feighny R, Burrous J, Henchal E, Hoke CH (1990). Protection of mice against lethal Japanese encephaltis virus with a recombinant baculovirus vaccine. Am I Trop Med Hyg 42: 491–499.
   PubMed Web of Science ®Google Scholar
• Men R, Bray M, Lai C-J (1991). Carboxy-terminal trun-cated dengue virus envelope glycoprotein expressed on the cell surface and secreted intracellularly exhibit increased immunogenicity in mice. I Virol 65: 1400-1407.
   Google Scholar
• Monath TP, Levenbook I, Soike K, Zhang ZX, Ratterree M, Draper K, Barrette ADT, Nichols R, Weltzin R, Arroyo J, Guirakhoo F (2000). Chimeric Yellow fever virus 17D-Japanese encephalits virus vaccine: dose-response effec-tiveness and extended safety testing in rhesus monkeys. I Virol 74: 1742–1751.
   PubMed Web of Science ®Google Scholar
• Monath TP, McCarthy K, Bedford P, Johnson CT, Nichols R, Yoksan S, Marchesani R, Knauber M, Wells KH, Arroyo J, Guirakhoo F (2002). Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 20: 1004–1018.
   PubMed Web of Science ®Google Scholar
• Moss B (1996). Genetically engineered poxviruses for re-combinant gene expression. Proc Nail Acad Sci U S A 93: 11341–11348.
   PubMed Web of Science ®Google Scholar
• Murthy HM, Judge K, DeLucas L, Padmanabhan R (2000). Crystal structure of Dengue virus N53 protease in com-plex with a Bowman-Birk inhibitor: implications for fla-viviral polyprotein processing and drug design. I Mol Biol 301: 759–767.
   Google Scholar
• Nam J-H, Wyatt LS, Chae S-L, Cho H-W, Park Y-K, Moss B (1999). Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes. Vaccine 17: 261–268.
   PubMed Web of Science ®Google Scholar
• Nestorowicz A, Chambers TJ, Rice CM (1994). Mutagene-sis of the yellow fever virus NS2A/B cleavage site: Ef-fects on proteolytic processing, viral replication, and ev-idence fro alternative processing of the NS2A protein. Virology 199: 114.
   PubMed Web of Science ®Google Scholar
• Nothdurft HD, Jelinek T, Marschang A, Maiwald H, Kapaun A, Loscher T (1996). Adverse reactions to Japanese en-cephalitis vaccine in travellers. /infect 32: 119–122.
   PubMed Web of Science ®Google Scholar
• Paoletti E (1996). Applications of pox virus vectors to vacci-nation: an update. Proc Nail Acad Sci USA 93: 11349–11353.
   PubMed Web of Science ®Google Scholar
• Rice CM (1996). Flaviviridae: the viruses and their replica-tion. In: Field's virology. Fields BN, Knipe PM, Howley PM (eds). Philadelphia: Lippencot-Raven, pp 931–959.
   Google Scholar
• Robinson HL, Torres CAT (1997). DNA vaccines. Semin Immunol 9: 271–283.
   PubMedGoogle Scholar
• Saini M, Vrati S (2003). A Japanese encephalitis virus pep-tide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge. I Virol 77: 3487–3494.
   PubMed Web of Science ®Google Scholar
• Schlesinger JJ, Brandriss MW, Cropp CB, Monath TP (1986). Protection against yellow fever in monkeys by immu-nization with yellow fever virus nonstructural protein NS1. I Virol 60: 1153–1155.
   PubMed Web of Science ®Google Scholar
• Schlensinger JJ, Brandiss MW, Walsh EE (1987). Protec-tion of mice against dengue 2 virus encephalitis by im-munization with dengue 2 virus non-structural protein NS1. I Gen Virol 68: 853–857.
   Google Scholar
• Schlensinger JJ, Foltzer M, Chapman S (1993). The Fc por-tion of antibody to yellow fever virus NS1 is a determi-nant of protection against yellow fever encephalitis in mice. Virology 192: 132–141.
   Google Scholar
• Seif SA, Morita K, Igarashi A (1996). A 27 amino acid cod-ing region of JE virus E protein expressed in E. coli as fu-sion protein with glutathione-S-transferase elicits neu-tralizing antibody in mice. Virus Res 43: 91–96.
   Google Scholar
• Seif SA, Morita K, Matsuo S, Hasebe F, Igarashi A (1995). Finer mapping of neutralizing epitope(s) onthe C-terminal of Japanese encephalitis virus E pro-tein expressed in recombinant Escherichia coli system. Vaccine 13: 1515–1521.
   PubMed Web of Science ®Google Scholar
• Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Nagamatu H, Igarashi A (1987). Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497–510.
   PubMed Web of Science ®Google Scholar
• Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC, Cox WI, Davis SW, van der Hoeven J, Meignier B, Riviere M (1992). NYVAC: a highly attenuated starin of vaccinia virus. Virology 188: 217–232.
   Google Scholar
• Taylor J, Trimarchi C, Weinberg R, Languet B, GuilleminF, Desmettre P, Paoletti E (1991). Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 9: 190–193.
   PubMed Web of Science ®Google Scholar
• Tine JA, Lanar DE, Smith DM, Wellde BT, Schulthesis P, Ware LA, Kayffm an EB, Wirtz RA, Detaisne C, HuiG, Chang SP (1996). NYVAC-Pf7-a poxvirus-vectored, multiantiger multistage vaccine candidate for Plas-modium falciparum malaria. Infect Immun 64: 3833–3844.
   PubMed Web of Science ®Google Scholar
• van den Hurk AF, Nisbet DJ, Johansen CA, Foley PN, Ritchie SA, Mackenzie JS (2001). Japanese encephalitis on Badu Island, Australia: the first isolation of Japanese en-cephalitis virus from Culex gelidus in the Australasian region and the role of mosquito host-feeding patterns in virus transmission cycles. Trans R Soc Trop Med Hyg 95: 595–600.
   Google Scholar
• Vrati S, Gin i RK, Razdan A, Malik P (1999). Complete nu-cleotide sequence of an Indian strain of Japanese en-cephalitis virus: sequence comparison with other strains and phylogenetic analysis. Am J Trop Med Hyg 61: 677–680.
   PubMed Web of Science ®Google Scholar
• Wengler G, Wengler G (1989). Cell-associated West Nile fla-vivirus is covered with E ± pre-M protein heterodimers which are destroyed and recognized by proteolytic cleavage during virus release. J Virol 63: 2521–2526.
   PubMed Web of Science ®Google Scholar
• Westaway EG, Mackenzie JM, Khromykh AA (2002). Repli-cation and gene function in Kunjin virus. Curr Top Microbic)] Immunol 267: 323–351.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1998). Japanese encephalitis vaccines. Wk/y Epidemiol Rec 73: 334–344.
   Google Scholar
• Xin YY, Ming ZG, Peng GY, Jian A, Min LH (1988). Safety of a live-attenuated Japanese encephalitis virus vaccine (5A14-14-2) for children. Am J Trop Med Hyg 39: 214–217.
   PubMed Web of Science ®Google Scholar
• Yasuda A, Kimura-Kiroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata C, Kojima A, Yasui K (1990). Induction of protective immunity in animals vac-cinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J Virol 64: 2788–2795.
   PubMed Web of Science ®Google Scholar